NCT00235170View on ClinicalTrials.gov

The Arterial Revascularization Therapies Study Part II.

PHASE3CompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

April 30, 2009

Conditions
Coronary Artery Disease
Interventions
DEVICE

drug-eluting stent

Cypher Sirolimus-eluting Coronary stent

Trial Locations (1)

3015 GD

Thoraxcenter, Erasmus Medical Center, Rotterdam

Sponsors

Lead Sponsor

Cordis Corporation
All Listed Sponsors
lead

Cordis Corporation

INDUSTRY

NCT00235170 - The Arterial Revascularization Therapies Study Part II. | Biotech Hunter | Biotech Hunter